Company: HCWB
Filing Date: 2025-03-28
Form Type: 10-K
Source: 0000950170-25-046724
Chunk: 77

Company: HCW Biologics Inc.
Filing Date: 2025-03-28
Form: 10-K
Item: Item 15
Chunk 77
---
 Warrant Purchase Agreement, dated November 18, 2024, between Company and Holder
     
    8-K
     
    011-40591
     
    4.2
     
    11/20/2024

    10.33
     
    Equity Purchase Agreement, dated February 20, 2025, between the Company and Square Gate Master Fund - Series 4.
     
    8-K
     
    011-40591
     
    10.1
     
    2/21/2025

    10.34
     
    Registration Rights Agreement, dated February 20, 2025, between the Company and Square Gate Master Fund - Series 4
     
    8-K
     
    011-40591
     
    10.2
     
    2/21/2025

    10.35
     
    Definitive Proxy Statement dated February 21, 2025, on Form 14A, including Appendices

    X

    23.1
     
    Consent of Independent Register Public Accounting Firm (Grant Thornton, Predecessor)

    X

    23.2
     
    Consent of Independent Registered Public Accounting Firm (Crowe, Successor)

    X

    31.1
     
    Certification of Chief Executive Officer pursuant to Rules 13a-14(a) and Rule 15d-14(a) of the Exchange Act

    X

    31.2
     
    Certification of Chief Financial Officer pursuant to Rules 13a-14(a) and Rule 15d-14(a) of the Exchange Act

    X

    32.1*
     
    Certification of Chief Executive Officer pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    X

136  

    32.2*
     
    Certification of Chief Financial Officer pursuant to Rule 13a-14(b) of the Exchange Act and 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

    X

    97.1
     
    HCW Biologics Inc. Compensation Recovery Policy